Lupin informs about press release

12 Nov 2020 Evaluate
Lupin has informed that it has enclosed press release titled ‘Lupins Alliance Partner Concord Receives USFDA Approval for Tacrolimus Capsules USP’.

The above information is a part of company’s filings submitted to BSE. 


Lupin Share Price

2138.65 -12.40 (-0.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×